In order to strengthen the construction of academic integrity of Journal of Pharmaceutical Research, standardize the process of paper writing, editing, and publishing, and resist academic misconduct, this journal has formulated ethical norms for authors, review experts, editors, and publishers of Journal of Pharmaceutical Research based on relevant provisions of copyright law, domestic and international publishing ethics, and in combination with the actual situation of this journal.
1. Author publication ethics
1) Multiple submission, duplicate publication, and split publication are strictly prohibited;
2) Ensure that the manuscript is an original work, free from academic misconduct such as plagiarism, forgery, and tampering, and promise that the manuscript does not involve confidential information;
3) Strictly adhere to the authorship guidelines for papers. Submitting authors must ensure that each author has made substantial academic contributions to the paper, and may not arbitrarily add or remove authors;
4) The fund projects involved in the paper should be accurately indicated in the manuscript, without any false indications (such as adding fund projects in the name of others, research content inconsistent with the fund projects, or fund projects that have been concluded);
5) Authors should ensure the quality of references cited and avoid unreasonable citation behaviors (plagiarism, excessive citations, anonymous citations, citing without marking, etc.);
6) Papers shall not be ghostwritten, submitted, or revised by "third parties", and false information about peer reviewers shall not be provided;
7) The manuscript should comply with biomedical ethics standards;
8) Respect the opinions of the review experts. If there are any objections, you may lodge a complaint with the editorial department.
2. Publication ethics of review experts
1) Understand the journal's positioning and review requirements, assess whether your professional knowledge and research direction align with the manuscript under review. If they do not align, promptly inform the editorial department to replace the reviewer;
2) Adhering to the principles of maintaining academic integrity and respecting academic freedom, one should scientifically and objectively evaluate the strengths and weaknesses of manuscripts, avoiding belittling, personal attacks, and making unfounded accusations;
3) We should adhere to the confidentiality principle of peer review, respect the research achievements of the authors, keep the content of the manuscript confidential, and refrain from using the authors' research results in violation of regulations;
4) One should examine potential conflicts of interest that may exist, and if any potential conflicts arise from the manuscript being reviewed, all relevant conflicts of interest should be declared to avoid conflicts of interest.
3. Ethics of editing and publishing
1) Handle each manuscript promptly and fairly: registration, preliminary review, submission for review, editing, and publication, etc;
2) Ensure confidential handling of submitted manuscripts;
3) Respect the results of peer review and final evaluation;
4) Supervise the objectivity and fairness of the review process conducted by reviewers;
5) Ensure that the content of the manuscript meets both publishing and academic standards.
4. Publisher ethics
1) This journal adheres to the principle of first publication and only reports original works;
2) Strictly abide by the regulations on obtaining papers;
3) Seriously handle academic misconduct and misconduct that infringes upon the rights and interests of this journal;
4) Journals should promptly update detailed submission guidelines and writing guidelines, etc;
5) Issue a timely errata statement.
5. Implementation
This specification shall come into effect from the date of its promulgation.
Editorial Department of Journal of Pharmaceutical Research
November 1, 2025